BioMarin Pharmaceutical Inc. (LON:0HNC)
London
· Delayed Price · Currency is GBP · Price in USD 59.16
-0.71 (-1.18%)
At close: Jul 10, 2025
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of 8.32 billion as of July 10, 2025. Its market cap has decreased by -33.99% in one year.
Market Cap
8.32B
Enterprise Value
7.82B
Revenue
2.28B
Ranking
n/a
PE Ratio
20.51
Stock Price
59.87
Market Cap Chart
Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 283.77M to 8.32B, an increase of 2,830.81%. That is a compound annual growth rate of 13.88%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 158.45B |
| GSK plc | 56.46B |
| Haleon | 33.36B |
| Smith & Nephew | 9.70B |
| ConvaTec Group | 5.38B |
| Hikma Pharmaceuticals | 4.37B |
| HUTCHMED (China) | 1.93B |
| Indivior | 1.43B |